TY - JOUR
T1 - Focus on risk factors for cardiometabolic disease in cerebral palsy
T2 - Toward a Core Set of Outcome Measurement Instruments
AU - Benner, Joyce L.
AU - McPhee, Patrick G.
AU - Gorter, Jan Willem
AU - Hurvitz, Edward A.
AU - Peterson, Mark D.
AU - Obeid, Joyce
AU - Wright, Marilyn
AU - Balemans, Astrid C.J.
AU - Verschuren, Olaf
AU - van den Berg-Emons, Rita H.J.
AU - van der Slot, Wilma M.A.
AU - Roebroeck, Marij E.
N1 - Funding Information:
This study is part of a clinical research project entitled ?Multimorbidity risk assessment and prevention through health-promoting behaviors (physical activity, nutrition, and sleep) in adolescents and adults with cerebral palsy,? funded by a Pedal-with-Pete grant from the American Academy for Cerebral Palsy and Developmental Medicine. Co-funding has been provided by Rijndam Rehabilitation, The Netherlands. Dr. Peterson is funded by the National Institutes of Health (grant no. 1KO1 HD074706) and the National Institute on Disability, Independent Living, and Rehabilitation Research (grant no. 90IF0102-01). Dr. Gorter holds the Scotiabank Chair in Child Health Research.
Publisher Copyright:
© 2019 American Congress of Rehabilitation Medicine
PY - 2019/12
Y1 - 2019/12
N2 - Objective: To identify existing outcome measurement instruments (OMIs) assessing risk factors for cardiometabolic disease in adolescents and adults with cerebral palsy (CP) reported on in the literature or used in the field. Data Sources: The COnsensus-based Standards for the selection of health Measurement Instruments database of systematic reviews and 4 electronic databases (Embase, MEDLINE/Ovid, MEDLINE/Pubmed, PsychINFO) were searched up to June 19, 2017, that yielded 2594 articles. Experts in the field were consulted to identify any additional OMIs. Study Selection: Two reviewers independently applied inclusion criteria to select eligible studies using or evaluating measurement properties of OMIs assessing 1 of 8 outcomes: cardiorespiratory endurance, body size, body composition, physical behavior, sleep, nutrition, blood pressure, and blood lipids and glucose. Studies with an experimental or observational design including ≥10 adolescents or adults with CP were included. Data Extraction: One reviewer extracted data that were summarized for study and sample characteristics, outcomes, OMIs used, and if applicable data on measurement properties. Two reviewers rated the methodological quality and the quality of the OMIs. Feasibility for clinical practice and research was rated by experts in the field. Data Synthesis: Ninety OMIs were identified from 56 included articles and by the experts. Seventy OMIs pertained to cardiorespiratory endurance, body size, body composition, and physical behavior, whereas only 5 were identified for sleep and nutrition. Overall synthesis revealed that there is moderate to poor evidence for good quality of OMIs in this population. Based on feasibility for clinical practice, experts agreed on a single OMI per outcome (and 2 for cardiorespiratory endurance) to be included in a core set. Conclusion: Despite the range of available OMIs to assess risk factors for cardiometabolic disease in adolescents and adults with CP, evidence of good quality is often lacking. Nonetheless, a preliminary core set of 9 OMIs was systematically developed.
AB - Objective: To identify existing outcome measurement instruments (OMIs) assessing risk factors for cardiometabolic disease in adolescents and adults with cerebral palsy (CP) reported on in the literature or used in the field. Data Sources: The COnsensus-based Standards for the selection of health Measurement Instruments database of systematic reviews and 4 electronic databases (Embase, MEDLINE/Ovid, MEDLINE/Pubmed, PsychINFO) were searched up to June 19, 2017, that yielded 2594 articles. Experts in the field were consulted to identify any additional OMIs. Study Selection: Two reviewers independently applied inclusion criteria to select eligible studies using or evaluating measurement properties of OMIs assessing 1 of 8 outcomes: cardiorespiratory endurance, body size, body composition, physical behavior, sleep, nutrition, blood pressure, and blood lipids and glucose. Studies with an experimental or observational design including ≥10 adolescents or adults with CP were included. Data Extraction: One reviewer extracted data that were summarized for study and sample characteristics, outcomes, OMIs used, and if applicable data on measurement properties. Two reviewers rated the methodological quality and the quality of the OMIs. Feasibility for clinical practice and research was rated by experts in the field. Data Synthesis: Ninety OMIs were identified from 56 included articles and by the experts. Seventy OMIs pertained to cardiorespiratory endurance, body size, body composition, and physical behavior, whereas only 5 were identified for sleep and nutrition. Overall synthesis revealed that there is moderate to poor evidence for good quality of OMIs in this population. Based on feasibility for clinical practice, experts agreed on a single OMI per outcome (and 2 for cardiorespiratory endurance) to be included in a core set. Conclusion: Despite the range of available OMIs to assess risk factors for cardiometabolic disease in adolescents and adults with CP, evidence of good quality is often lacking. Nonetheless, a preliminary core set of 9 OMIs was systematically developed.
KW - Cerebral palsy
KW - Rehabilitation
KW - Risk factors
KW - Systematic review
UR - https://www.scopus.com/pages/publications/85067306941
U2 - 10.1016/j.apmr.2019.04.012
DO - 10.1016/j.apmr.2019.04.012
M3 - Review article
C2 - 31128113
SN - 0003-9993
VL - 100
SP - 2389
EP - 2398
JO - Archives of Physical Medicine and Rehabilitation
JF - Archives of Physical Medicine and Rehabilitation
IS - 12
ER -